Pacific Biosciences Of California reported $19.27M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Accelerate Diagnostics AXDX:US 2.78M 625K
Agilent A:US $ 779M 33M
Bruker BRKR:US $ 290.2M 1.5M
Danaher DHR:US $ 3030M 47M
Fluidigm FLDM:US $ 28.7M 14.43M
General Electric GE:US $ 13605M 777M
Illumina ILMN:US $ 395M 13M
Myriad Genetics MYGN:US $ 49.7M 1.7M
Nanostring Technologies NSTG:US $ 15.85M 1.07M
Pacific Biosciences Of California PACB:US $ 19.27M 0.26M
Perkinelmer PKI:US $ 563.41M 16.8M
Thermo Fisher Scientific TMO:US $ 6240M 114M
Waters WAT:US $ 307.21M 21.52M